Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 11, 2011 - Issue 4
Submit an article Journal homepage
109
Views
12
CrossRef citations to date
0
Altmetric
Research Report

Impact of 5-HT3 RA selection within triple antiemetic regimens on uncontrolled highly emetogenic chemotherapy-induced nausea/vomiting

Lee Schwartzberg Accelerated Community Oncology Research Network, Memphis, TN, USA; The West Clinic, Memphis, TN, USA; Accelerated Community Oncology Research Network, Memphis, TN, USA; The West Clinic, Memphis, TN, USA
,
James Jackson Xcenda, 4114 Woodlands Parkway, Suite 500, Palm Harbor, FL 34685, USA;[email protected]
,
Gagan Jain Xcenda, 4114 Woodlands Parkway, Suite 500, Palm Harbor, FL 34685, USA
,
Sanjeev Balu Eisai, Inc., Woodcliff Lake, NJ, USA
&
Deborah Buchner Eisai, Inc., Woodcliff Lake, NJ, USA
Pages 481-488 | Published online: 09 Jan 2014

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Swetha Rao Palli, Michael Grabner, Ralph A Quimbo & Hope S Rugo. (2015) The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting. Cancer Management and Research 7, pages 175-188.
Read now
Sherry Mori-Vogt & Marlo Blazer. (2013) Palonosetron for the prevention of chemotherapy-induced nausea and vomiting. Expert Review of Anticancer Therapy 13:8, pages 919-936.
Read now
S Michael Roberts, Dmitri S Bezinover & Piotr K Janicki. (2012) Reappraisal of the role of dolasetron in prevention and treatment of nausea and vomiting associated with surgery or chemotherapy. Cancer Management and Research 4, pages 67-73.
Read now

Articles from other publishers (9)

Thiago Ramos Grigio, Angela Maria Sousa, Gabriel Guimarães Nunes Magalhães, Hazem Adel Ashmawi & Joaquim Edson Vieira. (2020) Aprepitant plus palonosetron for the prevention of postoperative nausea and vomiting after breast cancer surgery: a double blind, randomized trial. Clinics 75, pages e1688.
Crossref
David A. Johnson, David Lieberman, John M. Inadomi, Uri Ladabaum, Richard C. Becker, Seth A. Gross, Kristin L. Hood, Susan Kushins, Mark Pochapin & Douglas J. Robertson. (2017) Increased Post-procedural Non-gastrointestinal Adverse Events After Outpatient Colonoscopy in High-risk Patients. Clinical Gastroenterology and Hepatology 15:6, pages 883-891.e9.
Crossref
Eun Kyung Choi, Dong Gyeong Kim & Younghoon Jeon. (2016) Comparison of the Prophylactic Antiemetic Efficacy of Aprepitant Plus Palonosetron Versus Aprepitant Plus Ramosetron in Patients at High Risk for Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy: A Prospective Randomized-controlled Trial. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 26:5, pages 354-357.
Crossref
Camilo Rojas, Mithun Raje, Takashi Tsukamoto & Barbara S. Slusher. (2014) Molecular mechanisms of 5-HT3 and NK1 receptor antagonists in prevention of emesis. European Journal of Pharmacology 722, pages 26-37.
Crossref
Judith A. Smith, Paula Anastasia & Marc Rappaport. (2012) Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting with the Granisetron Transdermal System (GTDS): Three Clinical Perspectives on Three Case Studies in Solid Tumors. The Journal of Supportive Oncology 10:5, pages S1-S8.
Crossref
F. Longo, G. Mansueto, V. Lapadula, L. Stumbo, G. Del Bene, D. Adua, L. De Filippis, E. Bonizzoni & S. Quadrini. (2012) Combination of aprepitant, palonosetron and dexamethasone as antiemetic prophylaxis in lung cancer patients receiving multiple cycles of cisplatin‐based chemotherapy. International Journal of Clinical Practice 66:8, pages 753-757.
Crossref
Marigo Stathis, Claudio Pietra, Camilo Rojas & Barbara S. Slusher. (2012) Inhibition of substance P-mediated responses in NG108-15 cells by netupitant and palonosetron exhibit synergistic effects. European Journal of Pharmacology 689:1-3, pages 25-30.
Crossref
. (2012) Current World Literature. Current Opinion in Oncology 24:4, pages 454-460.
Crossref
Camilo Rojas & Barbara S. Slusher. (2012) Pharmacological mechanisms of 5-HT3 and tachykinin NK1 receptor antagonism to prevent chemotherapy-induced nausea and vomiting. European Journal of Pharmacology 684:1-3, pages 1-7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.